Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9781800 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8991586 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL2298322 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8816706 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8584856 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL486955 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL16832270 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL7543085 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL2293185 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL11160681 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524975-B2 | Amphiphilic compound having dendronic hydrophobic group and application thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2022-12-13 | — | — | US | disclosed |
| US-20200247836-A1 | NOVEL AMPHIPHILIC COMPOUND HAVING DENDRONIC HYDROPHOBIC GROUP AND APPLICATION THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2020-08-06 | — | — | US | disclosed |
| US-20160039879-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | S&T GLOBAL INC. (US) | 2016-02-11 | — | — | US | disclosed |
| EP-2137179-B1 | PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS | MERCK SHARP & DOHME (US) | 2015-09-02 | — | — | EP | disclosed |
| EP-2586778-A2 | Pyridazinone derivatives useful as glucan synthase inhibitors | Merck Sharp & Dohme Corp. (US) | 2013-05-01 | — | — | EP | disclosed |
| US-8232274-B2 | Pyridazinone derivatives useful as glucan synthase inhibitors | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-8232274-B2 | Pyridazinone derivatives useful as glucan synthase inhibitors | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-7749399-B2 | Method for producing flexographic printing plates using direct laser engraving | XSYS PRINT SOLUTIONS DEUTSCHLAND GMBH (DE) | 2010-07-06 | — | — | US | disclosed |
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. | 2009-07-02 | — | — | US | disclosed |
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. | 2009-07-02 | — | — | US | disclosed |
| EP-0306919-B1 | LIQUID CRYSTALLINE COMPOUNDS AND PROCESS FOR PRODUCTION THEREOF | DAISO CO., LTD. (JP) | 1993-02-17 | — | — | EP | disclosed |
| CN-1052667-A | OXAZOLE DERIVATIVES | BRISTOL MYERS SQUIBB CO (US) | 1991-07-03 | — | — | CN | disclosed |
| US-5026506-A | High capacity displays | SHARP KABUSHIKI KAISHA (JP) | 1991-06-25 | — | — | US | disclosed |
| EP-0410447-A2 | Liquid crystalline compounds, liquid crystal compositions containing the same and use thereof | DAISO CO., LTD. (JP) | 1991-01-30 | — | — | EP | disclosed |
| US-4973425-A | ELECTROOPTICS | DAISO CO., LTD. (JP) | 1990-11-27 | — | — | US | disclosed |
| US-4909957-A | Containing lactone ring structure | DAISO CO., LTD. (JP) | 1990-03-20 | — | — | US | disclosed |
| EP-0355830-A2 | Liquid crystal composition and use thereof | DAISO CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
| EP-0306919-A2 | Liquid crystalline compounds and process for production thereof | DAISO CO., LTD. (JP) | 1989-03-15 | — | — | EP | disclosed |
| US-4335012-A | LIQUID CRYSTALS | TIMEX CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| US-4322354-A | 5-Substituted-2-(4-cyanophenyl)-1,3,-dioxanes | TIMEX CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | MAN2A1, GYS2, MANBA | ZDHHC7 4416/4885CA2 3206/4885CA1 4563/4885 |
| US-20200247836-A1 | NOVEL AMPHIPHILIC COMPOUND HAVING DENDRONIC HYDROPHOBIC GROUP AND APPLICATION THEREOF | CETP, MDN1, TGOLN2 | ZDHHC7 482/4885CA2 3072/4885CA1 2828/4885 |
| US-11524975-B2 | Amphiphilic compound having dendronic hydrophobic group and application thereof | CETP, TGOLN2, MDN1 | ZDHHC7 424/4885CA2 2728/4885CA1 2525/4885 |
| US-20160039879-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | FKBP1B, MALT1, FKBP5 | ZDHHC7 425/4885CA2 1053/4885CA1 4107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.